A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

HeartStation Selects iBASIS eSIM for Remote Monitoring of AEDs to Ensure They Are Fully Powered and Operational in the Event of an Emergency

Today iBASIS, a provider of communications solutions for operators and digital players worldwide, announced that HeartStation, a global manufacturer of Automated External Defibrillator (AED) cabinets and accessibility products, has selected iBASIS eSIM for remote monitoring of AEDs to ensure they are fully powered and operational in the event of an emergency.

iBASIS’ selection follows one of the fastest implementations of its IoT solution to date, with field trials completed in just five days in late December 2019 and solution installed as of January 2020.

As the U.S. National Safety Council reports, greater access to AEDs could save 40,000 lives each year in the U.S. alone, and access to fully powered AEDs by bystanders can increase the odds of survival up to 40% and higher.1 The iBASIS eSIM enables dynamic monitoring of AEDs via an eSIM card installed within the AED cabinet. A signal is regularly monitored during the AED self-test, with automatic alerts to dispatch a technician should the device not meet the necessary operation.

Over 50,000 HeartStation AED units will be globally, remotely monitored via the iBASIS eSIM. The iBASIS solution is differentiated in its ability to enable dynamic routing selection of communications carrier in the cloud to drive the most effective network connectivity to remotely monitor and manage devices worldwide.

“The iBASIS eSIM is the perfect solution to further enhance the effectiveness of critical public access defibrillation programs by enabling remote monitoring of AEDs,” says Keith Hochhalter, President, HeartStation. “This solution ensures that devices will be fully available in critical circumstances, and we are very proud to partner with a company that shares our commitment to delivering life-changing innovation and performance.”

“HeartStation has developed unsurpassed capabilities for enhancing access to lifesaving devices,” says Ajay CTO, iBASIS. “We are extremely pleased to partner with them to deliver the remote monitoring needed to ensure their devices are always powered. We are also very happy with the incredible speed with which the teams have implemented the iBASIS eSIM capability. Our work with HeartStation reflects our commitment to enabling companies around the world to rapidly achieve the highest performance in management and monitoring of their products globally.”


Reference

1 Source: US National Safety Council

SourceiBASIS
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy